Article
Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer
30 Mar 2011
Abstract excerpt
INTRODUCTION: The IGF-1 receptor (IGF-1R) is a receptor tyrosine kinase and is well established as a key regulator of tumor cell growth and survival. There is also a growing body of data to support a role for the structurally and functionally related insulin receptor (IR) in human cancer. Bidirectional crosstalk between IGF-1R and IR is observed, where specific inhibition of either receptor confers a compensatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
